NumFin

Medical Developments International Limited

Simbol: MVP.AX

ASX

0.59

AUD

Tržna cena danes

  • -1.9991

    Razmerje P/E

  • -0.0070

    Razmerje PEG

  • 50.92M

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Medical Developments International Limited (MVP-AX) Finančni izkazi

Download
LetniČetrtletno
LinearnoLog
Na grafu so prikazane privzete številke v dinamiki za Medical Developments International Limited (MVP.AX). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

LetniČetrtletno
10Y20Y30Y40Y

Bilanca stanja

Če pogledamo fiskalno pot podjetja Medical Developments International Limited, opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003

balance-sheet.row.cash-and-short-term-investments

024.720.436.3
15.5
25.6
0.8
1.7
5.6
1
1.7
0.8
3.5
3.5
1.8
0.3
0.5
0.3
1
0.5
1.7
1.2

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3

balance-sheet.row.net-receivables

08.96.25
4.1
6.3
4.2
5.1
3.4
1.8
1.8
2.2
2
1.6
1
1.7
2
1.2
0.8
0.7
0.7
0.7

balance-sheet.row.inventory

08.47.15.7
5.9
3
3.2
2.4
2.7
1.9
1.4
1.4
1.1
0.9
1.5
1.4
1
1.4
1.4
1.4
1.2
0.9

balance-sheet.row.other-current-assets

00.80.60.4
0.4
0.4
0.5
0.6
4.4
0.2
0.7
0.5
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0

balance-sheet.row.total-current-assets

042.834.447.4
26
35.4
8.7
9.9
16.1
4.8
5.6
4.9
6.7
6.2
4.4
3.4
3.6
3
3.3
2.8
3.7
2.9

balance-sheet.row.property-plant-equipment-net

012.111.611.7
11.8
8.6
8.1
6.6
2.6
1.5
1.1
1
0.7
0.7
0.6
0.9
1
1.1
1.3
1.4
1.3
1.5

balance-sheet.row.goodwill

03.83.84.4
9.1
9.1
9.1
9.1
8.9
7.4
7.4
7.4
7.4
7.4
7.4
7.4
7.4
7.4
7.4
7
7.4
0

balance-sheet.row.intangible-assets

08.588.2
16.1
1.9
2
1.9
1.7
0.3
0.2
0.3
4.4
2.4
1.6
1.5
1.1
0.5
0.4
0
0
7.2

balance-sheet.row.goodwill-and-intangible-assets

012.311.812.6
25.2
11
11.1
11
10.5
7.7
7.6
7.6
11.8
9.8
9
8.8
8.4
7.9
7.8
7
7.4
7.2

balance-sheet.row.long-term-investments

0-3.8-3.8-4.4
-9.1
9.7
18.1
16.4
11.2
9.1
8.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

016.314.82.2
12.2
9.9
1.1
1.3
1.9
0.1
0.1
0
0
0
0.2
0.3
0.1
0.1
0.2
0.1
0.1
0

balance-sheet.row.other-non-current-assets

029.932.730.6
28.8
-19.6
-19.2
-1.3
-1.9
-0.1
-0.1
-8.7
0
0
0
0
0
0
0
0.2
0
0

balance-sheet.row.total-non-current-assets

066.76752.8
68.9
19.6
19.2
17.7
13.2
9.2
8.7
8.7
12.4
10.5
9.8
10
9.6
9.1
9.2
8.7
8.7
8.7

balance-sheet.row.other-assets

0000
0
29.8
21.6
14.2
12
8.9
8.2
6.7
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0109.5101.4100.2
94.9
84.8
49.5
41.8
41.2
23
22.6
20.3
19.1
16.7
14.2
13.4
13.2
12.1
12.5
11.6
12.5
11.6

balance-sheet.row.account-payables

013.39.43.3
3.8
2
2.1
1.8
2
0.8
0.7
1.2
1
0.6
0.7
0.7
0.7
0.2
0.2
0.2
0.2
0

balance-sheet.row.short-term-debt

00.40.30.3
0.4
0.1
0.1
0.1
0.1
0.1
3.1
1.4
0
0
0
0
0
0
0
0.5
1
1.5

balance-sheet.row.tax-payables

0000
0
2
0
0
4.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

02.22.52.7
2.9
0.1
9.1
0.3
0.3
1
0.6
0.1
0
0
0
0
0
0.3
2
2
1.5
2.5

Deferred Revenue Non Current

01.921.621.9
30
31.4
13
14.4
13
0.9
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.1
0.1
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01.60.73.3
1.6
3.8
1.5
1.3
4.9
0.9
0.5
0.6
1.1
1.3
0.5
0.6
0.3
0.5
0.3
0.4
0.9
0

balance-sheet.row.total-non-current-liabilities

012.633.624.9
43.3
0.1
9.1
0.3
0.3
1
0.6
0.1
0.8
0.4
0.3
0.3
0.3
0.4
2.1
2
2
2.6

balance-sheet.row.other-liabilities

0000
0
31.7
13.3
14.6
13.1
2.7
1.8
1.3
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

02.22.52.7
2.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

028.244.131.9
51.5
40.2
28.5
20.2
22.2
5.6
6.7
4.5
3
2.3
1.5
1.6
1.4
1.1
2.6
3.2
4.1
4.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0105.77776.9
41
40.4
16.1
15
11.9
10.9
10.9
10.6
9.4
7.3
7.3
7.3
8
8.1
8.1
7.9
7.9
7.5

balance-sheet.row.retained-earnings

0-30.2-24.5-12.1
0.4
2.7
4.2
6.3
6.9
6.4
4.9
5.2
6.7
7
5.2
4.3
3.7
2.8
1.6
0.5
0.5
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

05.74.93.5
2
1.5
0.7
0.3
0.3
0
0
0
0.1
0.2
0.2
0.2
0.2
0.1
0.1
-0.3
-0.1
0

balance-sheet.row.other-total-stockholders-equity

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
0.1
0

balance-sheet.row.total-stockholders-equity

081.357.368.3
43.3
44.6
21
21.6
19
17.4
15.8
15.7
16.2
14.5
12.7
11.8
11.8
11
9.9
8.4
8.4
7.5

balance-sheet.row.total-liabilities-and-stockholders-equity

0109.5101.4100.2
94.9
92.6
49.5
41.8
41.2
23
22.6
20.3
19.1
16.7
14.2
13.4
13.2
12.1
12.5
11.6
12.5
11.6

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

081.357.368.3
43.3
44.6
21
21.6
19
17.4
15.8
15.7
16.2
14.5
12.7
11.8
11.8
11
9.9
8.4
8.4
7.5

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0-3.8-3.8-4.4
-9.1
9.7
18.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3

balance-sheet.row.total-debt

02.62.83
3.4
0.2
9.3
0.4
0.5
1.1
3.7
1.4
0
0
0
0
0
0.3
2
2
2.5
4

balance-sheet.row.net-debt

0-22.1-17.6-33.2
-12.2
-25.4
8.5
-1.3
-5.1
0.2
2
0.7
-3.5
-3.5
-1.8
-0.3
-0.5
-0.1
1
1.5
0.8
3

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Medical Developments International Limited opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004

cash-flows.row.net-income

0-5.6-12.4-12.6
0.4
1
0.2
1.8
1.6
1.5
0.9
2.3
2.7
1.7
0.9
0.8
0.9
1.2
0.8
0.2
0.5

cash-flows.row.depreciation-and-amortization

03.12.93.7
2.6
1.2
0.8
0.5
0.4
0.3
0.3
0.2
0.2
0.4
0.4
0.4
0.3
0.2
0.2
0.6
0.3

cash-flows.row.deferred-income-tax

0-7.4-8.4-0.1
2
-1
0
0.6
-3.5
0
0
0.6
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

01.311.2
0.1
0.4
-0.2
0
0.3
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-2.5-3.6-9.9
-0.2
-1.9
0.2
2.5
-6.5
-0.5
0.4
-0.6
0
0
0
0
0
0
0
0
0

cash-flows.row.account-receivables

0-2.9-2.51.4
2.3
-2.1
0.9
2.3
-5.7
0
0.5
-0.3
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-1.8-1.40.2
-2.8
0.1
-0.8
0.2
-0.8
-0.4
-0.1
-0.3
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

04.82.31
2
0.2
0.5
0.2
1.3
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-2.6-2.1-12.5
-1.7
-0.2
-0.5
-0.2
-1.3
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

0-5.49.88.9
-4.3
21.7
0.8
-1.5
19.8
2
-0.3
-0.9
-3
-2.1
-1.2
-1.2
-1.2
-1.5
-1
-0.8
-0.8

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-7.7-5.2-6.6
-8.9
-1.5
-2.1
-4.4
-1.4
-0.6
-0.3
-0.5
-2.2
-1.3
-0.3
-0.6
-0.8
-0.1
-0.3
-0.3
-0.1

cash-flows.row.acquisitions-net

0000
0
0
0
0
-2
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.2
-9

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
0
-8
-8.6
-4.3
-2.7
-1
-1.5
-2.4
0
0
0
0
0.2
0
0.1
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-7.7-5.2-6.6
-8.9
-9.5
-10.7
-8.7
-6.2
-1.5
-1.8
-3
-2.2
-1.3
-0.3
-0.6
-0.6
-0.1
-0.2
-0.6
-9.1

cash-flows.row.debt-repayment

0-0.3-0.2-0.1
-0.1
-9.1
-0.1
-0.1
-0.6
-2.6
0
0
0
0
0
-0.8
-0.3
-1.8
-0.6
-1
-0.5

cash-flows.row.common-stock-issued

028.30.436.3
0.4
23.8
0.4
2
0
0
0
0.1
0.1
0
0
0
0
0
0
0
8.7

cash-flows.row.common-stock-repurchased

0-1.70-0.7
0
-1
0
0
0.6
0
0
0
0
0
0
-0.8
-0.2
0
0
0
-0.8

cash-flows.row.dividends-paid

0-26.4-0.1-35.5
-2.1
-1.7
-1.2
-1.2
-0.6
0
-0.8
-2.3
-1.2
0
0
0
0
0
0
-0.1
0

cash-flows.row.other-financing-activites

028.10.136.1
-0.2
1
8.9
0
0
0
2.2
1.4
0
0
0
0.8
0
0
0.1
0
3

cash-flows.row.net-cash-used-provided-by-financing-activities

028.10.136.1
-2
13
8
0.7
-1.3
-2.6
1.5
-0.7
-1.1
0
0
-0.8
-0.4
-1.8
-0.5
-1.1
10.4

cash-flows.row.effect-of-forex-changes-on-cash

00.4-0.10
0.2
0
0
0
0
0
0
0
0
0
0
-0.1
0
0
0
0
0

cash-flows.row.net-change-in-cash

04.3-15.920.7
-10.1
24.8
-0.9
-3.9
4.7
-0.7
0.9
-2.7
-0.1
1.8
1.5
-0.2
0.1
-0.7
0.5
-1.2
1.3

cash-flows.row.cash-at-end-of-period

024.720.436.3
15.5
25.6
0.8
1.7
5.6
1
1.7
0.8
3.5
3.5
1.8
0.3
0.5
0.3
1
0.5
1.7

cash-flows.row.cash-at-beginning-of-period

020.436.315.5
25.6
0.8
1.7
5.6
1
1.7
0.8
3.5
3.5
1.8
0.3
0.5
0.3
1
0.5
1.7
0.4

cash-flows.row.operating-cash-flow

0-16.5-10.7-8.8
0.6
21.3
1.8
4
12.1
3.4
1.3
1
3.2
0
0
1.3
1.2
1.3
1.2
0.6
0

cash-flows.row.capital-expenditure

0-7.7-5.2-6.6
-8.9
-1.5
-2.1
-4.4
-1.4
-0.6
-0.3
-0.5
-2.2
-1.3
-0.3
-0.6
-0.8
-0.1
-0.3
-0.3
-0.1

cash-flows.row.free-cash-flow

0-24.2-15.9-15.4
-8.3
19.8
-0.3
-0.3
10.6
2.8
1
0.4
1
-1.3
-0.3
0.7
0.4
1.1
0.9
0.2
-0.1

Vrstica izkaza poslovnega izida

Prihodki Medical Developments International Limited so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja MVP.AX znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003

income-statement-row.row.total-revenue

032.321.925.3
22.5
20.9
17.5
18.3
15.5
11.6
9.4
11.7
11.3
10.2
8.3
8.7
9.2
7.4
6.6
5.4
3
5.5

income-statement-row.row.cost-of-revenue

034.9258.6
8.8
6.7
5.1
5.8
4.3
3.6
3
3.4
3.5
3.7
3
3
3.5
2.5
2.2
1.9
1
0

income-statement-row.row.gross-profit

0-2.5-3.116.7
13.7
14.2
12.4
12.6
11.2
8.1
6.3
8.3
7.8
6.5
5.3
5.7
5.7
4.9
4.4
3.5
2
5.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

019.100
0
0
0
1.9
1.1
0.1
0
0
0.2
0.1
0.1
0.1
0.1
0.1
0
0
0
-3.1

income-statement-row.row.operating-expenses

017.812.621.9
11.9
13
11.9
10.1
8.9
5.8
5.5
5.2
4.7
4.7
4.4
5
4.8
3.4
3.3
3.6
1.6
0.3

income-statement-row.row.cost-and-expenses

052.637.630.5
20.7
19.7
17
15.9
13.2
9.4
8.6
8.6
8.1
8.3
7.4
8
8.3
5.9
5.5
5.5
2.6
0.3

income-statement-row.row.interest-income

00.70.50.1
0.3
0.4
0.1
0
0
0.1
0.1
0
0.2
0.1
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

00.10.10.1
0.1
0.1
0.1
0
0
0.1
0.2
0
0
0
0
0
0
0.1
0.2
0.2
0.1
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

012.8-0.2-9.7
-1.6
-1.6
-1.8
-1
-1.3
-0.8
-1.1
-0.6
0.2
0.1
0.1
0.1
0.1
0.1
0
0
0
-3.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

019.100
0
0
0
1.9
1.1
0.1
0
0
0.2
0.1
0.1
0.1
0.1
0.1
0
0
0
-3.1

income-statement-row.row.total-operating-expenses

012.8-0.2-9.7
-1.6
-1.6
-1.8
-1
-1.3
-0.8
-1.1
-0.6
0.2
0.1
0.1
0.1
0.1
0.1
0
0
0
-3.1

income-statement-row.row.interest-expense

00.10.10.1
0.1
0.1
0.1
0
0
0.1
0.2
0
0
0
0
0
0
0.1
0.2
0.2
0.1
0

income-statement-row.row.depreciation-and-amortization

03.12.93.7
2.6
1.2
0.8
0.5
0.4
0.3
0.3
0.2
0.2
0.4
0.4
0.4
0.3
0.2
0.2
0.6
0.3
0.3

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-20.3-15.7-5.2
1.9
3.2
2.1
3.5
3.6
2.9
1.7
3.8
3.2
1.9
0.9
0.7
0.9
1.5
1.1
-0.1
0.4
5.1

income-statement-row.row.income-before-tax

0-7.5-15.9-15
0.3
1.6
0.3
2.5
2.3
2.2
0.6
3.2
3.8
2.5
1.3
1.2
1.3
1.7
1.2
0.4
0.7
2

income-statement-row.row.income-tax-expense

0-1.9-3.5-2.4
-0.1
0.5
0.1
0.6
0.7
0.6
0.2
0.9
1.1
0.8
0.4
0.4
0.4
0.5
0.4
0.4
0.7
2

income-statement-row.row.net-income

0-5.6-12.4-12.6
0.4
1
0.2
1.8
1.6
1.5
0.9
2.3
2.7
1.7
0.9
0.8
0.9
1.2
0.8
0.2
0.5
0
Podobne delnice
Morda vas zanima tudi:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

Pogosto zastavljeno vprašanje

Kaj je Medical Developments International Limited (MVP.AX) skupna sredstva?

Medical Developments International Limited (MVP.AX) skupna sredstva so 109486000.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je -0.215.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -0.239.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -0.574.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -0.750.

Kaj je Medical Developments International Limited (MVP.AX) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -5609000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 2560000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 17757000.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.